US SEC Trading Suspension Halt Orders — May 18, 2026
Two regulatory filings on May 18, 2026 highlight contrasting listing statuses: Palatin Technologies voluntarily delists from NYSE American to transfer to Nasdaq Capital Market, maintaining its symbol PTN, while Synergy CHC Corp. faces a Nasdaq deficiency notice for failing to maintain the $1.00 bid price, with a 180-day cure period until November 11, 2026. Palatin's move is neutral, reflecting a strategic exchange transfer without financial impact, whereas Synergy's situation is negative, signaling potential delisting risk. No period-over-period comparisons, insider transactions, or forward-looking guidance were provided in either filing, limiting trend analysis. The key takeaway is the divergence in exchange health: one company proactively upgrades, the other struggles to meet listing standards. Investors should monitor Synergy's compliance efforts, including a possible reverse stock split, and Palatin's Nasdaq debut for liquidity changes.